Related Experiment Video
Updated: Feb 5, 2026

Visualization of Endoplasmic Reticulum Subdomains in Cultured Cells
Published on: February 18, 2014
GPR177 promotes gastric cancer proliferation by suppressing endoplasmic reticulum stress-induced cell death
Jaesung Seo1, Seung-H Lee1, Soo-Y Park1
1Department of Biochemistry and Molecular Biology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
Gastric cancer is the fourth most common cancer worldwide. Despite the high incidence of gastric cancer, efficient chemotherapy treatments still need to be developed. In this study, we examined the anticancer effects of endoplasmic reticulum (ER) stress inducer tunicamycin in gastric cancer. Previously, we found that overexpression of WLS1/GPR177 correlated with poor prognosis in patients with gastric cancer. Furthermore, tunicamycin treatment downregulated GPR177 expression in a dose-dependent manner. GPR177 transports WNT ligand from ER to the plasma membrane, mediating its secretion to the extracellular matrix. In gastric cancer cells, GPR177 preferentially localizes to the ER. Small interfering RNA-mediated knockdown of GPR177 leads to sensitization to ER stress and induces apoptosis of cancer cells along with tunicamycin treatment. GPR177 suppression promoted the ER stress-mediated proapoptotic pathway, such as PERK-CHOP cascade. Furthermore, fluorouracil treatment combined with tunicamycin dramatically reduced cancer cell proliferation. Efficacy of tunicamycin chemotherapy treatments depended on GPR177 expression in gastric cancer cell lines. Together, our results indicate that ER stress can potentiate anticancer effects and suggest GPR177 as a potential gastric cancer therapeutic target.
Insights
This study shows endoplasmic reticulum (ER) stress can fight gastric cancer. Inhibiting GPR177 enhances chemotherapy, suggesting it as a therapeutic target for this common cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Gastric cancer is a leading global malignancy with limited effective chemotherapy options.
- Overexpression of WLS1/GPR177 is linked to poor prognosis in gastric cancer patients.
- GPR177 facilitates WNT ligand transport from the endoplasmic reticulum (ER) for secretion.
Purpose of the Study:
- To investigate the anticancer effects of tunicamycin, an ER stress inducer, in gastric cancer.
- To explore the role of GPR177 in gastric cancer cell response to ER stress and chemotherapy.
Main Methods:
- Utilized tunicamycin to induce ER stress in gastric cancer cells.
- Examined GPR177 expression levels and localization.
- Employed small interfering RNA (siRNA) to knockdown GPR177.
- Assessed apoptosis and cell proliferation using various treatments, including fluorouracil.
Main Results:
- Tunicamycin downregulated GPR177 expression in a dose-dependent manner.
- GPR177 knockdown sensitized gastric cancer cells to ER stress and tunicamycin-induced apoptosis.
- GPR177 suppression enhanced the ER stress-mediated PERK-CHOP proapoptotic pathway.
- Combination of fluorouracil and tunicamycin significantly reduced cancer cell proliferation.
- Tunicamycin's efficacy was dependent on GPR177 expression levels.
Conclusions:
- Endoplasmic reticulum stress can enhance anticancer effects in gastric cancer.
- GPR177 plays a crucial role in gastric cancer cell survival under ER stress.
- GPR177 represents a potential therapeutic target for improving gastric cancer chemotherapy.
Related Concept Videos
Endoplasmic Reticulum
The Endoplasmic Reticulum
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Directing Proteins to the Rough Endoplasmic Reticulum
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

